Loading...
Loading...
India's sitagliptin imports from UNITED STATES total $7.3M across 187 shipments from 15 foreign suppliers. Raff & Hall Pharmacy leads with $6.2M in import value; the top 5 suppliers together control 95.4% of this origin. Leading Indian buyers include MSN LABORATORIES PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for sitagliptin — a diversified sourcing base with multiple active suppliers from UNITED STATES.

Raff & Hall Pharmacy is the leading Sitagliptin supplier from UNITED STATES to India, with import value of $6.2M across 3 shipments. The top 5 suppliers — Raff & Hall Pharmacy, Good Health Pharma Supplies, ESPEE BIOPHARMA & FINECHEM LLC, NEWLIFE MEDICALS (USA).INC., Espee Biopharma & Finechem LLC — collectively account for 95.4% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | Raff & Hall Pharmacy | $6.2M | 3 | 84.7% |
| 2 | Good Health Pharma Supplies | $536.8K | 3 | 7.3% |
| 3 | ESPEE BIOPHARMA & FINECHEM LLC | $114.1K | 33 | 1.6% |
| 4 | NEWLIFE MEDICALS (USA).INC. | $69.1K | 1 | 0.9% |
| 5 | Espee Biopharma & Finechem LLC | $68.3K | 23 | 0.9% |
| 6 | GRANULES PHARMACEUTICALS INC | $37.1K | 8 | 0.5% |
| 7 | M/S NEW CITY RX LLC | $30.7K | 5 | 0.4% |
| 8 | M/S ESPEE BIOPHARMA & FINECHEM LLC | $30.4K | 5 | 0.4% |
| 9 | NEWLIFE MEDICALS (USA). INC | $22.6K | 3 | 0.3% |
| 10 | SPRING BIO SOLUTION | $21.1K | 7 | 0.3% |
| 11 | ESPEE BIOPHARMA & FINECHEM LLC. | $20.8K | 1 | 0.3% |
| 12 | NEW LIFE MEDICALS (USA) INC | $18.4K | 4 | 0.2% |
| 13 | NEWLIFE MEDICALS (USA). INC. | $16.3K | 5 | 0.2% |
| 14 | ESPEE BIOPHARMA FINECHEM LLC | $16.1K | 8 | 0.2% |
| 15 | AMSTERDAM PHARMA APTEKA RX INC | $15.1K | 6 | 0.2% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | MSN LABORATORIES PRIVATE LIMITED | $6.3M | 9 | 85.2% |
| 2 | HETERO LABS LIMITED | $541.4K | 8 | 7.4% |
| 3 | UMEDICA LABORATORIES PRIVATE LIMITED | $93.1K | 7 | 1.3% |
| 4 | MANKIND PHARMA LIMITED | $57.9K | 13 | 0.8% |
| 5 | GRANULES INDIA LIMITED | $37.1K | 11 | 0.5% |
| 6 | MYLAN LABORATORIES LIMITED | $34.0K | 22 | 0.5% |
| 7 | INVENTIA HEALTHCARE LIMITED | $33.3K | 6 | 0.5% |
| 8 | CHEMO INDIA FORMULATION PRIVATE LIMITED | $30.7K | 5 | 0.4% |
| 9 | UNICHEM LABORATORIES LIMITED | $22.6K | 3 | 0.3% |
| 10 | LAURUS LABS LIMITED | $22.0K | 3 | 0.3% |
| 11 | AKUMS DRUGS AND PHARMACEUTICALS LIMITED | $20.5K | 3 | 0.3% |
| 12 | LUPIN LIMITED | $19.2K | 3 | 0.3% |
| 13 | CENTAUR PHARMACEUTICALS PRIVATE LIMITED | $18.4K | 4 | 0.2% |
| 14 | MANKIND PHARMA LTD | $16.3K | 5 | 0.2% |
| 15 | PAR FORMULATIONS PRIVATE LIMITED | $13.8K | 4 | 0.2% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Sitagliptin suppliers from UNITED STATES to India include Raff & Hall Pharmacy, Good Health Pharma Supplies, ESPEE BIOPHARMA & FINECHEM LLC. The leading supplier is Raff & Hall Pharmacy with import value of $6.2M USD across 3 shipments. India imported Sitagliptin worth $7.3M USD from UNITED STATES in total across 187 shipments.
India imported Sitagliptin worth $7.3M USD from UNITED STATES across 187 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Sitagliptin sourced from UNITED STATES include MSN LABORATORIES PRIVATE LIMITED, HETERO LABS LIMITED, UMEDICA LABORATORIES PRIVATE LIMITED. The largest buyer is MSN LABORATORIES PRIVATE LIMITED with $6.3M in imports across 9 shipments.
The total value of Sitagliptin imports from UNITED STATES to India is $7.3M USD, across 187 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
187 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists